Moderate levels of alcohol consumption linked to higher risk of some cancers, NCI writes in JAMA

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Even moderate levels of alcohol consumption appear to be associated with a higher risk of some cancers—including cancers of the female breast—as well as adverse cardiovascular health effects, NCI researchers wrote in JAMA.

The article, “Alcohol and Cancer: Research and Clinical Implications,” is co-authored by three associate directors in the Division of Cancer Control and Population Sciences at NCI.

The paper highlights the low awareness of the association between alcohol use and cancer and makes a call for increasing clinician knowledge and patient-provider communication regarding the effects of alcohol on cancer. The authors also supports increased focus and research on the harms of moderate drinking, in addition to the more commonly studied harms from risky drinking and alcohol use disorders.

Alcohol is associated with almost 90,000 cases of cancer of the oral cavity, throat, liver, female breast, and colorectum per year. Awareness of this relationship is low not only in the U.S., but worldwide. The paper also notes evidence that reductions in alcohol use are associated with decreased cancer mortality.

Table of Contents

YOU MAY BE INTERESTED IN

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings.
At the 2026 Annual Meeting of the American Society of Clinical Oncology in Chicago, results from the phase III HARMONi-6 trial were presented at the plenary session and published simultaneously in The Lancet. The HARMONi-6 trial tested a novel bispecific antibody that engages PD-1 and VEGF (ivonescimab), given with platinum-doublet chemotherapy to patients with previously untreated advanced squamous non-small cell lung cancer. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login